Additional value of interleukin-6 level to predict histopathological features of hepatocellular carcinoma before liver transplantation

•Inflammatory biomarkers are used as outcome predictors in oncology.•Liver transplantation is the best treatment for hepatocellular carcinoma.•The organ shortage implies to avoid futile liver transplantation.•IL6 at transplantation is a predictor of pejorative histological features.•IL6 at transplantation is an associated to the risk of recurrence.